Abstract:Introduction: The blood-brain barrier (BBB) is composed of specialized endothelial cells that limit the passage of solutes from the blood to the brain. Microfluidic technology that allows formation of 3D tubular microvessels has been applied to in vitro BBB models, and having advantages of fluid flow, cell-cell contact, provide a more robust and predictive model for assessing vascular permeability. Use of the microfluidic model to examine the effects of the tumor microenvironment on brain endothelial cell permeability would provide mechanistic fundamental knowledge that could be used to more effectively deliver therapeutic agents to the treatment site. Methods: Human brain microvessel endothelial cells (hCMEC/d3) were seeded (10,000 cells/μL) into the vascular channel and following vascular capillary tube formation, various human brain tumor cell lines (SF8628, U87, and U251) were seeded in the adjacent brain channel of the Mimeta 3-channel microfluidic unit. Tumor-induced alterations in barrier function were examined over a 72-hour period using paracellular (fluorescein-labeled detran-FDX70kD; IRdye 800; sodium fluorescein - NaF) and transcellularly transported dyes (rhodamine 800-R800). Tumor induced changes in permeability of various marker molecules were correlated to changes in the expression of selected BBB specific genes and the tumor secretome. Results: The microfluidic BBB culture model showed reduced permeability to all the permeability markers examined compared to TranswellTM inserts with values similar to those previously reported in vivo. Compared to monoculture, no significant changes in permeability were observed with U251 co-culture model. However, SF8628 enhanced barrier properties, while U87 increased paracellular leakiness. Examination of the barrier enhancing microenvironment observed with the SF8628 co-culture model indicated a Sonic Hedgehog dependent process that stimulates the release of Angiopoietin 1 (Ang1) and Platelet derived growth factor (PDGF-BB) release from the SF8628 tumor cells as the likely factors driving the permeability effects observed. With regards to the increased permeability observed with the U87 co-culture, increased cytokines (ie. IL-6 and IL-8) and altered fatty acid secretion appear to play a significant role in the reduced barrier properties of brain endothelial cells. Conclusion: The brain tumor microenvironment can have either barrier enhancing (SF8628 co-culture) or barrier reducing (U87-co culture) effects based on tumor cell induced changes in secreted factors. The dynamic microfluidic blood-brain barrier - brain tumor co-culture model provides a robust system with which to mechanistically identify tumor-driven changes in brain endothelial cell permeability. Citation Format: Stacey Line, Magimairajan Issai Vanan, Donald W. Miller. Development and validation of a microfluidic cell culture model for examining cerebral microvascular barrier responses to the tumor microenvironment [abstract]. In: Proceedings of the AACR Special Conference on Brain Cancer; 2023 Oct 19-22; Minneapolis, Minnesota. Philadelphia (PA): AACR; Cancer Res 2024;84(5 Suppl_1) nr A048.

Blood-tumor barrier in focus - investigation of glioblastoma-induced effects on the blood-brain barrier

Blood-tumor barrier organoids recapitulate glioblastoma microenvironment and enable high-throughput modeling of therapeutic delivery

Modulation of blood-tumor barrier transcriptional programs improves intra-tumoral drug delivery and potentiates chemotherapy in GBM

Biom-40. Blood And Nasal Biomarkers Of Brain Microenvironment Blood–Brain Barrier Permeability: Clinical And Applied Concepts

Abstract P20: Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma using an Advanced Human in vitro Model of the Blood-brain Barrier and Glioblastoma

Development of a human in vitro blood–brain tumor barrier model of diffuse intrinsic pontine glioma to better understand the chemoresistance

Regulation of pathological blood-brain barrier for intracranial enhanced drug delivery and anti-glioblastoma therapeutics

Abstract 2501: A glioblastoma and blood-brain barrier in vitro model to assess the tumor microenvironment and temozolomide resistance

Optical blood-brain-tumor barrier modulation expands therapeutic options for glioblastoma treatment

Are In Vitro Human Blood–Brain–Tumor-Barriers Suitable Replacements for In Vivo Models of Brain Permeability for Novel Therapeutics?

Abstract A048: Development and validation of a microfluidic cell culture model for examining cerebral microvascular barrier responses to the tumor microenvironment

Engineering a High-Throughput 3-D In Vitro Glioblastoma Model

Establishment and Validation of a New Co-Culture for the Evaluation of the Permeability through the Blood–Brain Barrier in Patients with Glioblastoma

A predictive microfluidic model of human glioblastoma to assess trafficking of blood-brain barrier-penetrant nanoparticles

Targeting Glioma Stem Cell-Derived Pericytes Disrupts the Blood-Tumor Barrier and Improves Chemotherapeutic Efficacy

Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy

Exploring the Impact of Irradiation on Glioblastoma Blood-Brain-Barrier Permeability: Insights from Dynamic-Contrast-Enhanced-MRI and Histological Analysis

Molecular Crosstalk between T Cells and Tumor Uncovers GBM-Specific T Cell Signatures in Blood: Noninvasive GBM Diagnosis Using Immunosensors

GLIOMA-14 ELUCIDATING THE CELL-CELL INTERACTIONS AND GEO-SPATIAL ORIENTATION OF M2 POLARIZED MACROPHAGES/MICROGLIA WITHIN GBM'S TME AND INVESTIGATING THEIR IMMUNOSUPPRESSIVE EFFECT ON DENDRITIC CELLS

Blood–Brain Barrier in Brain Tumors: Biology and Clinical Relevance